527
Participants
Start Date
May 31, 2003
Primary Completion Date
January 31, 2004
Study Completion Date
January 31, 2004
Bromfenac
One drop in study eye every 12 hours for 14 days
Placebo
One drop in study eye every 12 hours for 14 days
Ophthalmic Consultants of Long Island, Rockville Centre
Scheie Eye Institute, Philadelphia
Virginia Eye Consultants, Norfolk
Horizon Eye Care, Charlotte
Advanced Eye Care, PC, Fort Oglethorpe
Marvin E Greenberg, MD, PA, Tamarac
Jack Daubert, MD, West Palm Beach
Cohen Laser Vision Center, Boca Raton
Brandon Cataract Center & Eye Clinic, Brandon
Harold A Helms, MD, Birmingham
Middle Tennessee Eye Associates, Cookeville
Cincinnati Eye Institute NKY, Edgewood
Great Lakes Eye Care, Saint Joseph
Black Hills Regional Eye Institute, Rapid City
Hunkeler Eye Institute, Kansas City
Donald E Beahm, MD, Great Bend
Tulane University Health Sciences Center, New Orleans
Stevenson Medical Surgical Eye Center, New Orleans
Eye Care Arkansas, PA, Little Rock
Dean A McGee Eye Institute, Oklahoma City
The Eye Institute, Tulsa
Houston Eye Associates, Houston
Ophthalmology Visual Science, Galveston
David G Shulman, MD, San Antonio
Ophthalmology Service, Brooke Army Medical Center, Fort Sam Houston
Central Texas Eye Center, San Marcos
Texan Eye Care PA, Austin
E Randy Craven, MD, Littleton
Saltzer Medical Group, PA, Nampa
Arthur J Weinstein, MD, Albuquerque
Eye Care of San Diego, San Diego
Anesthetic Eye Care Institute, Newport Beach
UCI, Department of Ophthalmology, Irvine
Santa Clara Valley Medical Center, San Jose
Richard A Lewis, MD, Sacramento
Casey Eye Institute, Portland
Eye Health Northwest, Portland
The Eye Care Group, New Haven
Cornea Consultants, Boston
Bausch & Lomb Incorporated
INDUSTRY